Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/29/2015 07/30/2015 07/31/2015 08/03/2015 08/04/2015 Date
0.685(c) 0.65(c) 0.67(c) 0.6301(c) 0.625(c) Last
187 651 50 602 74 370 105 025 82 226 Volume
+7.03% -5.11% +3.08% -5.96% -0.81% Change
More quotes
Financials ($)
More Financials
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
07:01a Cyclacel Pharmaceuticals to Release Second Quarter 2015 Financial Results
07/13 CYCLACEL PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
07/03 CYCLACEL PHARMACEUTICALS : First Patient Dosed in IST of CDK Inhibitor Selicicli..
07/02 First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's Disease, ..
06/29 Cyclacel & ManRos Therapeutics Announce Licensing & Supply Agreement Regardin..
06/29 CYCLACEL PHARMACEUTICALS : & ManRos Therapeutics Announce Licensing & Supply Agr..
06/18 CYCLACEL PHARMACEUTICALS : to Present at 10th Annual JMP Securities Healthcare C..
06/17 Cyclacel Pharmaceuticals to Present at 10th Annual JMP Securities Healthcare ..
More news
Sector news : Bio Therapeutic Drugs
06:02a EUROPA-MERGERS : Commission approves acquisition of Hospira by Pfizer, subject t..
08/04 Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
08/04 Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/13 Cyclacel Pharma revenues up 25% in Q1
05/12 Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q1 2015 Results - Earn..
05/12 Cyclacel Pharmaceuticals beats by $0.06
04/15 Midday Gainers / Losers
03/25 Cyclacel Pharma ups revenues 55% in FY14


Comments 
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Technical analysis trends CYCLACEL PHARMACE...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions